Sen. John Boozman (R-AR) Buys Albemarle Corporation Shares
Senator John Boozman disclosed purchasing Albemarle stock, valued between $1,001 and $15,000.
Financial Disclosure Report
Secretary of the Senate • Office of Public Records • 232 Hart Senate Office Building • Washington, DC 20510
Filer Information
- Name:
- Sen. John Boozman (R-AR)
- Status:
- Member — Senate
- State/District:
- AR
- Party:
- republican
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Jun 16, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Albemarle Corporation ($ALB) | Buy | May 15, 2026 | $1,001 - $15,000 |
Key Points
- Senator John Boozman, a Republican from Arkansas, bought shares of Albemarle Corporation valued between $1,001 and $15,000 on May 15, 2026.
- Albemarle Corporation, trading at $160.35 on Sunday, operates in the specialty chemicals industry and has a market cap of $18.91 billion.
- Recent insider activity at Albemarle saw CEO Kent Masters selling shares, while analysts maintained 'buy' ratings with price targets up to $264.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Senator John Boozman, a Republican from Arkansas, recently disclosed a purchase of shares in Albemarle Corporation (NYSE:ALB). The transaction, executed on May 15, 2026, was valued between $1,001 and $15,000. This purchase was reported on June 16, 2026, as part of the STOCK Act's requirements for public officials to disclose stock trades.
John Boozman vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in Albemarle Corporation
Several major funds have also been active in Albemarle Corporation. Capital World Investors increased its holdings by 1,097,659 shares, bringing its total to 9,835,390 shares valued at approximately $1.77 billion. BlackRock, Inc. added 537,561 shares, ending with 8,734,837 shares worth about $1.57 billion. Vanguard Capital Management LLC opened a new position with 7,662,216 shares valued at roughly $1.38 billion. Similarly, Vanguard Portfolio Management LLC initiated a stake of 6,315,377 shares, valued at around $1.13 billion. Meanwhile, State Street Corp reduced its position by 461,807 shares, leaving it with 5,224,378 shares valued at $940 million.
Albemarle Corporation Stock Down 2.5%
Shares of NYSE:ALB traded near $160.35 on Sunday. Albemarle Corporation, a leader in the specialty chemicals industry, has a market capitalization of approximately $18.91 billion. The company's forward P/E ratio stands at 12.84, and it has a beta of 1.309, indicating a higher volatility compared to the market. Over the past year, the stock has seen a low of $55.90 and a high of $221.00. The 50-day moving average is $181.19, while the 200-day moving average is $146.14. Albemarle maintains a current ratio of 2.068 and a quick ratio of 1.11, with a debt-to-equity ratio of 19.845.
$ALB stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Albemarle Corporation reported revenue of $5.49 billion, with a growth rate of 32.7%. Despite this, the company posted a negative net margin of -4.24% and a return on equity of -1.82%. The next earnings report is expected on July 29, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
8 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 166.8%. Revenue beat estimates by 7.2%.
-
Profit surprise
EBITDA missed by 36 percent. Operating income beat by 41 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
8 target raises.
-
Earnings quality
Gross margin up 20.7 points. Operating margin up 14.7 points. Positive free cash flow.
Earnings Call Summary
Albemarle had a strong first quarter with $1.43 billion in revenue, up 33 percent from last year, and $664 million in adjusted earnings, more than double the prior year. The company benefited from higher lithium prices (up 51 percent), increased volumes in Energy Storage of 14 percent, and successful cost cutting that saved $40 million so far this year. The company paid down $1.3 billion of debt, improving its financial flexibility, and generated $248 million in free cash flow in the quarter.
Guidance Management raised their full year outlook for the Specialties business, now expecting between $1.3 billion and $1.5 billion in sales and $225 million to $275 million in adjusted earnings. They kept their Energy Storage outlook unchanged despite supply chain disruptions from the Middle East, estimating the cost impact at $70 million to $90 million. The company expects to offset these costs through lower interest expense from debt paydown and better than expected Specialties pricing and volumes.
Good report. The company beat and showed some forward improvement, with a few meaningful caveats.
Insider Buying and Selling at Albemarle Corporation
Recent insider activity at Albemarle Corporation includes sales by Chairman and CEO Kent Masters. On May 15, 2026, Masters sold 16,393 shares at an average price of $183.72. Earlier in the year, he sold 30,716 shares on March 12, 2026, at $162.79 and 11,783 shares on March 10, 2026, at $170.81. Meanwhile, insider Alejandro Daniel Wolff purchased 25 shares on April 1, 2026.
Analysts Set New Price Targets
Analysts have maintained optimistic views on Albemarle Corporation. On May 26, 2026, RBC Capital maintained its 'buy' rating with a price target of $257. Similarly, Scotiabank kept its 'buy' rating with a target of $215 on May 14, 2026. Argus Research also upheld a 'buy' rating on May 11, 2026, with a target of $230. The consensus recommendation remains a 'buy', with an average target price of $213.97 based on 22 analyst opinions.
About Albemarle Corporation
Albemarle Corporation is a global leader in providing specialty chemicals, with its headquarters in Charlotte, North Carolina. The company operates through three main segments: Energy Storage, Specialties, and Ketjen. Albemarle is known for its production of lithium compounds used in batteries for consumer electronics and electric vehicles. Led by CEO Jerry Kent Masters Jr., Albemarle employs around 7,800 people and serves a wide range of industries, including automotive, aerospace, and pharmaceuticals.
Bottom Line
Senator John Boozman's recent purchase of Albemarle shares highlights the company's appeal to investors. Albemarle's diverse product offerings in the specialty chemicals sector and its strategic importance in energy storage make it a stock to watch. As always, it's important to remember that this disclosure reflects past activity and may not indicate Boozman's current holdings.
Get Albemarle Corporation alerts
New 13F filings, insider trades, and analyst moves on $ALB, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.